|
Contents
|
|
|
|
Oligodendroglioma
|
|
|
|
|
Chamberlain MC, Glantz MJ
CPT-11
for recurrent temozolomide-refractory 1p19q co-deleted anaplastic
oligodendroglioma
J Neurooncol.
2008 Sep;89(2):231-8. Epub 2008 May 15
.JPG)
Abstract
|
|
|
Taillibert S, Vincent LA, Granger B, Marie Y,
Carpentier C, Guillevin R, Bellanger A, Mokhtari K, Rousseau A, Psimaras D,
Dehais C, Sierra del Rio M, Meng Y, Laigle-Donadey F, Hoang-Xuan K, Sanson
M, Delattre JY
Bevacizumab
and irinotecan for recurrent oligodendroglial tumors
Neurology. 2009 May
5;72(18):1601-6
Abstract
|
|
|
Non-CNS Tumors
|
|
|
|
Mori
K, Kondo T, Kamiyama Y, Kano Y, Tominaga K
Preventive
effect of Kampo medicine (Hangeshashin-to) against irinotecan-induced diarrhea
in advanced non-small-cell lung cancer
Cancer Chemother Pharmacol 2003 Apr 9; [epub ahead of print]
|
|
|
Topoisomerase
I inhibitors
|
|
|
|
Ewesuedo
RB, Ratain MJ
Topoisomerase
I Inhibitors
Oncologist 1997;2(6):359-364 (PDF Full Text)
|
|
